
0:00
5:00
A quiet week for top-tier acromegaly papers, with a useful surgical-outcome predictor and a new treatment-landscape review, while rare disease industry news was dominated by setbacks: a failed Becker muscular dystrophy trial, deep Ultragenyx layoffs, and a new safety signal for Zolgensma.
More episodes from "Acromegaly Update"



Don't miss an episode of “Acromegaly Update” and subscribe to it in the GetPodcast app.








